United States blood glucose monitoring devices market stood at USD3088.16 million in 2020 and is expected to grow at a steady CAGR of 7.53% during the forecast period. This can be attributed to the growing prevalence of diabetes among the population in the country especially among the geriatric population. Additionally, increase awareness pertaining to diabetes care, prevention, treatment, and management among the population is further expected to support the market growth over the next few years. Besides, technological advancements and new product launches by the major players operating in the market is further expected to support the market growth during the forecast period.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

The sudden outbreak and spread of COVID-19 pandemic across the globe and with United States being severely affected by the pandemic created new opportunities for the growth of the United States blood glucose monitoring devices market. The implementation of lockdown in order to control the virus spread led to various kinds of changes in the routine of people suffering from diabetes majorly their eating habits, physical activities, etc. This in turn impacted the glucose levels of the patients leading to different types of fluctuations in their blood glucose levels thereby increasing the demand for blood glucose monitoring devices, especially the self blood glucose monitoring devices. Additionally, in the post pandemic time also when most of the population in the United States is vaccinated, the demand for glucose monitoring devices is expected to increase significantly in the coming years since diabetic patients are more susceptible to COVID-19 and associated complications.

Growing Prevalence of Diabetes Supporting Market Growth

The growing prevalence of diabetes directly supports the growth of blood glucose monitoring devices market. According to the US Centers for Disease Control (CDC) National Diabetes Statistics Report 2020, the number of diabetic cases rose to 34.2 million in 2018 which is almost about 10.5% of the US population. Of these 34.2 million about 26.8 million had diagnosed diabetes while 7.3 million people had diabetes but were not diagnosed. In 2018, an estimated 1.5 million new cases of diabetes were diagnosed among US adults aged 18 years or older.

Increasing Healthcare Expenditure to Support Market Growth

The healthcare spending in the US increased by 4.6% in 2019 which amounted to USD3.8 trillion, which was 17.7% of the GDP as compared to 17.6% in 2018. The medicare spending increased by 6.7% in 2019 which accounted for 21% of the National Healthcare spending. The healthcare spending is expected to reach USD6.2 trillion by 2028, growing at a CAGR of 5.4% between 2019 and 2028.

New Product Launches to Support Market Growth

 

The ongoing technological advancements and healthcare innovations are leading towards the launch of various new blood glucose monitoring devices, both self blood glucose monitoring devices and continuous glucose monitoring devices. For instance, in February 2021, F. Hoffmann-La Roche AG announced the launch of the new Accu-Chek Instant system. This system will support and enable Roche’s approach of integrated Personalized Diabetes Management (iPDM). This system features Bluetooth-enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app. Furthermore, increasing number of regulatory approvals by the US Food and Drug Administration will further lead to the launch of various new products in the next few years.


Click here to download the sample


Market Segmentation

The United States blood glucose monitoring devices market is segmented based on product, application, end user, company, and regional distribution. Based on product, the market can be split into self blood glucose monitoring devices and continuous blood glucose monitoring devices. Self blood glucose monitoring devices market can be further categorized into test strips, lancets, and glucometers. Continuous glucose monitoring devices can be further segmented into sensors, transmitters & receivers, and integrated insulin pumps. Based on application, the market can be fragmented into type 2 diabetes, type 1 diabetes, and gestational diabetes. Based on end user, the market can be categorized into home care settings, hospital & clinics, and others.

Company Profiles

Abbott Laboratories, Inc., Medtronic USA Inc., Roche Diagnostics Corporation, Dexcom, Inc., B. Braun Medical Inc., Becton, Dickinson, and Company, Sanofi-Aventis U.S. LLC, Insulet Corporation, Nipro Medical Corporation, Terumo Medical Corporation, etc. are among the major market players in the United States blood glucose monitoring devices market.

Attribute

Details

Market Size Value in 2020

USD3088.16 Million

Revenue Forecast in 2026

USD4689.97 Million

Growth Rate

7.53%

Base Year

2020

Historical Years

2016 – 2019

Estimated Year

2021

Forecast Period

2022 – 2026

Quantitative Units

Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product

Application

End user

Regional Scope

South, Midwest, West & North-East

Key Companies Profiled

Abbott Laboratories, Inc., Medtronic USA Inc., Roche Diagnostics Corporation, Dexcom, Inc., B. Braun Medical Inc., Becton, Dickinson, and Company, Sanofi-Aventis U.S. LLC, Insulet Corporation, Nipro Medical Corporation and Terumo Medical Corporation

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, United States blood glucose monitoring devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Blood Glucose Monitoring Devices Market, By Product:
    • Self Blood Glucose Monitoring Devices
    • Continuous Glucose Monitoring Devices
  • United States Blood Glucose Monitoring Devices Market, By Application:
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Gestational Diabetes
  • United States Blood Glucose Monitoring Devices Market, By End User:
    • Home Care Settings
    • Hospital & Clinics
    • Others
  • United States Blood Glucose Monitoring Devices Market, By Region:
    • South
    • Midwest
    • West
    • North-East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States blood glucose monitoring devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Blood Glucose Monitoring Devices Market

4.    Executive Summary

5.    Voice of Customers

5.1.  Brand Awareness

5.2.  Factors Affecting Purchase Decision

5.3.  Vendor Satisfaction Analysis

5.4.  Sources of Information

6.    United States Blood Glucose Monitoring Devices Market Outlook, 2016-2026F

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Self Blood Glucose Monitoring Devices v/s Continuous Glucose Monitoring Devices)

6.2.2.     By Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes)

6.2.3.     By End User (Home Care Settings, Hospital & Clinics, Others)

6.2.4.     By Region

6.2.5.     By Company (2020)

6.3.  Product Market Map

7.    United States Self Blood Glucose Monitoring Devices Market Outlook, 2016-2026F

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Test Strips, Lancets, Glucometer)

7.2.2.     By Application

7.2.3.     By End User

8.    United States Continuous Glucose Monitoring Devices Market Outlook, 2016-2026F

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Test (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)

8.2.2.     By Application

8.2.3.     By End User

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends and Developments

11.  Policy & Regulatory Landscape

12.  United States Economic Profile

13.  Competitive Landscape

13.1.    Competition Outlook

13.2.    Company Profiles

13.2.1.  Abbott Laboratories, Inc.

13.2.2.  Medtronic USA Inc.

13.2.3.  Roche Diagnostics Corporation

13.2.4.  Dexcom, Inc.

13.2.5.  B. Braun Medical Inc.

13.2.6.  Becton, Dickinson, and Company

13.2.7.  Sanofi-Aventis U.S. LLC

13.2.8.  Insulet Corporation

13.2.9.  Nipro Medical Corporation

13.2.10. Terumo Medical Corporation

14.  Strategic Recommendations

15.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]
  • Figure 1: United States Blood Glucose Monitoring Devices Market Size, By Value (USD Million), 2016-2026F

    Figure 2: United States Blood Glucose Monitoring Devices Market Share, By Product, By Value, 2016-2026F

    Figure 3: United States Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2016-2026F

    Figure 4: United States Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2016-2026F

    Figure 5: United States Blood Glucose Monitoring Devices Market Share, By Region, By Value, 2016-2026F

    Figure 6: United States Blood Glucose Monitoring Devices Market Share, By Company, By Value, 2020

    Figure 7: United States Blood Glucose Monitoring Devices Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2020

    Figure 8: United States Self Blood Glucose Monitoring Devices Market Size, By Value (USD Million), 2016-2026F

    Figure 9: United States Self Blood Glucose Monitoring Devices Market Share, By Type, By Value, 2016-2026F

    Figure 10: United States Self Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2016-2026F

    Figure 11: United States Self Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2016-2026F

    Figure 12: United States Continuous Glucose Monitoring Devices Market Size, By Value (USD Million), 2016-2026F

    Figure 13: United States Continuous Glucose Monitoring Devices Market Share, By Type, By Value, 2016-2026F

    Figure 14: United States Continuous Glucose Monitoring Devices Market Share, By Application, By Value, 2016-2026F

    Figure 15: United States Continuous Glucose Monitoring Devices Market Share, By End User, By Value, 2016-2026F